EUCTR2019-001633-14-IT进行中(未招募)1 期
A single-centre, open-label pilot study to assess the efficacy and safety of CBD oral solution as an adjunctive treatment for pediatric subjects with Developmental and Epileptic Encephalopathy - CBD_DEE
IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA0 个研究点目标入组 20 人开始时间: 2021年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •oMale or female;
- •oAged between 2 and 7 years;
- •oA documented history of DEE [7];
- •oCurrently taking at least 1 other AED between one and four AEDs, with a stable antiseizure treatment for the previous 4 weeks (including ketogenic diet and vagus nerve stimulation);
- •oInadequately seizure control with 2 or more current or prior AEDs;
- •oWritten informed consent provided by the participant and/or parent(s)/caregiver(s).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •oClinically significant unstable medical or psychiatric conditions that may place patient’s safety at risk;
- •oClinically significant liver disease or serum aminotransferase (ALT or AST) >3 times the upper limit of the normal range or total bilirubin >2 times the upper limit of the normal range or international normalized ratio (INR) >1.5;
- •oKnown or suspected intolerance or hypersensitivity to cannabinoids or any of the excipients of the medicinal product such as sesame oil;
- •oCurrent use of ACTH or other systemic steroids;
- •oCurrent use (or use in the previous 2 months) of medicinal cannabis, or synthetic cannabinoid-based medications;
- •oInadequate supervision by parent(s)/caregiver(s) in the judgment of investigators
- •oStable felbamate dosing = 1 year;
- •oSubjects who have been part of a clinical trial involving another investigational product in the previous six months;
- •oSubjects with severe renal impairment: estimated glomerular filtration rate (eGFR) calculated as crCL < 30 ml/min, according to Schwartz equation.
研究者
相似试验
撤回
1 期
A SINGLE CENTER OPEN-LABEL PILOT STUDY TO EVALUATE THE TOLERABILITY AND SAFETY OF A SYNTHETIC SOFT TISSUE IMPLANT MATERIAL IN THE SKIN OF NORMAL VOLUNTEERSTolerability and safety of a new synthetic soft tissue implant material for soft tissue augmentation in healthy volunteers.Surgery - Other surgeryACTRN12607000223437COSMETREND PTY LTD8
已完成
1 期
A single center, open-labeled, pilot study to evaluate the safety and efficacy of cardiac cycle-synchronized electrical lower limb muscle stimulation therapy for cardiovascular diseaseatent heart failure (NYHA class: II-III), ischemic heart disease (CCS class: II-III), peripheral artery disease (Fontaine class: II-IV), pulmonary artery hypertension (WHO class: II-III), and healthy adultJPRN-UMIN000026841Kurume University School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine30
招募中
1 期
Pentosan Polysulfate Sodium (PPS) in subjects with mucopolysaccharidosis type I (MPS I)Mucopolysaccharidosis type I (MPS I)Metabolic and Endocrine - Metabolic disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12620000823976Paradigm Biopharmaceuticals Pty Ltd10
尚未招募
1 期
Biocompatible & Biodegradable Polymeric Skin Grafts for WoundsCTRI/2020/11/029284SASTRA Deemed University
招募中
1 期
A pilot single center, open label trial to assess the impact of doxycycline postexposure prophylaxis on antimicrobial resistance (SafeDoxyPEP trial)Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)CTIS2023-507137-24-00Institute Of Tropical Medicine78
